Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
74.15 (1y: +43%)
Market Cap 184.32 B P/E(ttm) 19.10
Enterprise Value 199.22 B P/B 2.62
NVS- NYSE (USA)
Novartis AG
  • Currently 4/5
Business Predictability Rank: 4-Star
Back Testing Results:
Average gain of all 4-Star stocks: 9.8% per year.
% of Stocks that are in still loss if held for 10yrs: 8%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$74.15
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M184,316Revenue $M57,854Net Margin (%)16.5Z-Score2.8
Enterprise Value $M195,923EPS $4.0Operating Margin %20.0F-Score7
P/E(ttm))19.1Cash Flow Per Share $5.5Pre-tax Margin (%)19.5Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %7.7Quick Ratio0.8Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %4.9Current Ratio1.2Lower Leverage y-yY
Price/Cash Flow11.3y-y EBITDA Growth Rate %59.1ROA % (ttm)7.7Higher Current Ratio y-yY
Dividend Yield %3.4Insider Buy (3m)0ROE % (ttm)13.8Less Shares Outstanding y-yN
Payout Ratio %50.0Shares Outstanding M2,421ROI % (ttm)14.9Gross Margin Increase y-yN

Gurus Latest Trades with NVS

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 80. The trades of Premium Gurus are not included unless they are in your Personalized List

TickerDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
NVS2012-03-31 Reduce-0.14%$53.31 - $58.33
($52.37)		 $ 74.1542%Reduce -22.44%515,000
NVS2010-12-31 Reduce-0.34%$53.41 - $59.77
($57.3)		 $ 74.1529%Reduce -35.87%643,500
NVS2010-03-31 Buy 0.96%$51.91 - $55.52
($54.06)		 $ 74.1537%New holding, 1002250 sh.1,002,250
NVS2009-12-31 Sold Out -0.24%$49.56 - $56.16
($53.34)		 $ 74.1539%Sold Out0
NVS2009-09-30 Reduce-0.12%$39.22 - $49.41
($45)		 $ 74.1565%Reduce -50%250,000
NVS2008-12-31 Buy 0.74%$43.85 - $50.99
($47.7)		 $ 74.1556%New holding, 500000 sh.500,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 6

NVS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NVS Lee Ainslie 2013-03-31531,6890.020.49New Buy
NVS Ken Fisher 2013-03-315,268,7910.221+4.56%
NVS Tweedy Browne 2013-03-31301,9340.010.56+0.18%
NVS Jean-Marie Eveillard 2013-03-3113,06000
NVS Chris Davis 2013-03-3133,10000.01
NVS Mario Gabelli 2013-03-3110,94000.01
NVS Dodge & Cox 2013-03-3147,505,2721.964.2-1.93%
NVS HOTCHKIS & WILEY 2013-03-312,256,5350.090.82-2.47%
NVS PRIMECAP Management 2013-03-3127,436,7291.132.9-3.42%
NVS John Hussman 2013-03-31416,9000.021.1-13.31%
NVS Irving Kahn 2013-03-3133,45600.35-21.03%
NVS Vanguard Health Care Fund 2013-03-31726,2000.030.2-85.39%
Premium Most recent portfolio changes are included for Premium Members only!


NVS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about NVS:

Quarterly/Annual Reports about NVS:

    News about NVS:

    Articles On GuruFocus.com
    20 Mega Caps and Their Dividend Payments and Which to Consider May 17 2013 
    20 Best-Yielding Health Care Stocks - Less Volatile Than the Market Apr 02 2013 
    10 Best Dividend Paying Drug Manufacturing Stocks Mar 02 2013 
    Dodge & Cox Explain Why They Are Overweight in Pharmaceuticals Dec 13 2012 
    Is Novartis a Good Buy Right Now? Nov 28 2012 
    The Fiscal Cliff and its Impact to your Portfolio Nov 15 2012 
    Tweedy Browne Q3 Letter Nov 01 2012 
    Ken Fisher’s Top Mega-Cap New Purchases in Q3 Oct 18 2012 
    The 20 Biggest Healthcare Dividend Payer Oct 02 2012 
    A Look at Two Undervalued Small-Cap Health Care Stocks Aug 09 2012 

    More From Our Partners
    Good News for Novartis' Ilaris - Analyst Blog May 15 2013 - ZACKS

    Add Notes, Comments or Ask Questions

    Comments

    No comment yet
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
    Free 7-day Trial